Silent atrial fibrillation is atrial fibrillation that produces no noticeable symptoms. Your heart’s upper chambers quiver irregularly, just as they do in standard AFib, but you don’t feel palpitations, shortness of breath, fatigue, or dizziness. Roughly one-third of all AFib cases are silent, meaning the person has no idea their heart rhythm is abnormal until it’s caught on a monitor, during a routine exam, or after a complication like stroke.
Why Some People Don’t Feel It
In typical AFib, the chaotic electrical signals in the upper heart chambers often push the heart rate up noticeably, creating the fluttering or racing sensation most people associate with the condition. Silent AFib episodes tend to be shorter and slower, with less variation in heart rate. That smaller disruption stays below the threshold most people can perceive.
Individual differences in nerve sensitivity also play a role. The heart has its own network of sensory nerves that relay information about rhythm changes to the brain. Some people simply have a higher threshold for detecting those signals, much like how some people sleep through loud noises while others wake at the slightest sound. Age, diabetes, and prior heart procedures can all dull nerve sensitivity in and around the heart, making it more likely that AFib episodes go unnoticed.
The Stroke Risk Is Higher, Not Lower
The absence of symptoms does not mean the absence of danger. In fact, silent AFib carries a higher stroke risk than the symptomatic version. Data from the large GLORIA-AF registry found that patients with asymptomatic AFib had a 2.3-fold greater risk of stroke compared to those with symptomatic AFib. In that study, 12.5% of asymptomatic AFib patients had a history of stroke or presented with one at the time of diagnosis, versus 5% of patients who had symptoms.
The reason is timing. People with symptomatic AFib tend to get diagnosed earlier because their symptoms prompt a visit to a doctor. Silent AFib can persist for months or years before anyone catches it. During that window, the upper chambers aren’t contracting properly, which lets blood pool and form clots. Those clots can travel to the brain and cause a stroke. By the time silent AFib is discovered, the cumulative exposure to that clot-forming environment has often been much longer.
How Silent AFib Gets Discovered
Because there are no symptoms to prompt a visit, silent AFib is typically found in one of a few ways: an irregular pulse noticed during a routine physical, an unexpected finding on an EKG done for another reason, or a diagnostic workup after a stroke that has no other obvious cause (called a cryptogenic stroke).
European cardiology guidelines give a class I recommendation for people over 65 to routinely check their own pulse. This simple self-check, pressing two fingers to the inside of your wrist and feeling for an irregular rhythm, costs nothing and can be the first clue.
Wearable Devices
Consumer smartwatches have become a practical screening tool. The Apple Watch achieves a sensitivity above 95% and a specificity above 80% for detecting AFib, meaning it catches most true episodes while occasionally flagging a false alarm. The KardiaBand from AliveCor performs similarly, with 93% sensitivity and 84% specificity. These devices use optical sensors or single-lead electrical readings on your wrist to spot irregular rhythms, and they can catch episodes that happen while you’re asleep or otherwise occupied.
A smartwatch notification is not a diagnosis, but it’s a strong reason to follow up with a proper EKG or longer-term monitor.
Implantable Monitors
For people who have already had a stroke with no identified cause, doctors sometimes place a small implantable loop recorder under the skin of the chest. This device continuously records heart rhythm for up to three years. In a registry of 241 cryptogenic stroke patients who received one, 19.5% were ultimately diagnosed with AFib. The detection rate was 10.4% at six months and 12.4% at one year, illustrating how intermittent and elusive silent episodes can be.
When Short Episodes Start to Matter
One of the trickiest questions in silent AFib is how long an episode needs to last before it warrants treatment. Current stroke guidelines consider AFib clinically actionable when episodes last 30 seconds or longer. But in real-world monitoring with implanted devices, episodes lasting six minutes or more are commonly used as the threshold for considering blood thinners.
The ARTESIA trial provided key evidence here: blood thinners reduced stroke risk in patients whose silent AFib episodes lasted between 6 minutes and 24 hours, though with a trade-off of increased bleeding risk. This means even very brief, symptom-free episodes can be clinically meaningful, particularly if you have other stroke risk factors like high blood pressure, diabetes, or a prior stroke.
What Happens If It Goes Untreated
Beyond stroke, prolonged untreated AFib can weaken the heart muscle over time. When the upper chambers fire too fast for too long, the lower chambers (which do the heavy pumping) have to keep up with that abnormal pace. Over months or years, this extra workload can stretch and weaken the heart, leading to a form of heart failure. Because silent AFib offers no warning signals, this gradual decline can progress undetected.
AFib also tends to beget more AFib. Early episodes are often intermittent, coming and going on their own. But the longer the condition persists without intervention, the more the heart’s electrical system remodels itself in ways that sustain the arrhythmia. What starts as occasional brief episodes can eventually become a constant state that’s harder to treat and reverse.
How It’s Managed Once Found
Treatment for silent AFib follows the same principles as symptomatic AFib, with one important distinction: the goal is almost entirely about preventing complications rather than relieving symptoms you’re already feeling. The cornerstone is stroke prevention, which for most people means blood-thinning medication. Your doctor will assess your individual stroke risk using factors like age, sex, blood pressure history, and whether you’ve had a prior stroke or heart failure.
Rate control, using medication to keep the heart from beating too fast during episodes, is often part of the plan even when you don’t feel those fast beats. Slowing the rate protects the heart muscle from the gradual weakening that sustained fast rhythms can cause. In some cases, rhythm control strategies (medications or procedures aimed at restoring a normal rhythm) are appropriate, especially if monitoring reveals frequent or prolonged episodes.
Regular follow-up monitoring becomes especially important because you can’t rely on symptoms to tell you whether the condition is getting better or worse. Many people with silent AFib use periodic wearable monitoring or longer-term patch monitors to track whether episodes are becoming more frequent or lasting longer, information that guides ongoing treatment decisions.